Kuros Strengthens Orthobiologics Patent Portfolio

Kuros Biosurgery was granted U.S. Patent No. 10,589,001, "Pharmaceutical formulation for use in spinal fusion," addressing the use of parathyroid hormone containing matrices for spinal fusion.

The company's Dutch subsidiary, Kuros Biosciences, was granted U.S. Patent 10,561,683, “Method for producing an osteoinductive calcium phosphate and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us